RE-BVS – Piemonte Repository

Sfoglia per AUTORE
FERREIRA C
Collezione AOU San Luigi di Orbassano

Items : 3

Sotorasib versus docetaxel for previously treated KRAS G12C-mutated non-small-cell lung cancer: a plain language summary. in Future oncology (London, England) / Future Oncol. 2025 Mar 24:1-12. doi: 10.1080/14796694.2025.2474789.

2025
AOU San Luigi di Orbassano

de Langen AJ; Johnson ML; Mazieres J; Dingemans AC; Mountzios G; Pless M; Wolf J; Schuler M; Lena H; Skoulidis F; Yoneshima Y; Kim SW; Linardou H; Novello S; van der Wekken AJ; Chen Y; Peters S; Felip E; Solomon BJ; Ramalingam SS; Dooms C; Lindsay CR; Ferreira CG; Blais N; Obiozor CC; Wang Y; Mehta B; Varrieur T; Ngarmchamnanrith G; et alii...

Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago. in World journal of emergency surgery : WJES / World J Emerg Surg. 2024 Apr 16;19(1):14. doi: 10.1186/s13017-024-00543-w.

2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Agnoletti V; Catena F; Baiocchi GL; Bravi F; Vallicelli C; Coccolini F; Sartelli M; Banchini F; Capelli P; Reames S; Cairl N; Biffl WL; Truong HP; Schaffer K; Curtiss W; McClure A; Austin TR; Hyman TS; Quick JA; Hemmila M; Napolitano LM; Sangji NF; Armento I; Egodage T; Coffua LS; Echeverria-Rosario K; Ratnasekera A; Seng SS; Bardes JM; et alii...

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial. in Lancet (London, England) / Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7.

2023
AOU San Luigi di Orbassano